N Zimmermann1, M Wünscher2, U Schlötzer-Schrehardt3, C Erb1. 1. Augenheilkunde, Augenklinik am Wittenbergplatz, Berlin. 2. Augenheilkunde, Augen-Tagesklinik Warschauer Straße, Berlin. 3. Augenklinik, Universität Erlangen-Nürnberg, Erlangen.
Abstract
INTRODUCTION: Pseudoexfoliation (PEX) syndrome is a common, age-related disease which is associated with the multifocal deposition of fibrillar PEX material in intra- and extraocular tissues. Subsequently among others second chronic open-angle glaucoma and corneal endothelial cell loss occurs. The present study analysed whether there is a correlation between the stage of the PEX process and corneal endothelial cell density (cECD), regardless of the non-existence or proof of secondary glaucoma. MATERIALS AND METHODS: One eye of 109 Caucasian subjects (mean age 71.7 years) was examined by slit-lamp microscopy and classified based on visible PEX deposits on the lens (mild and severe) and presence of glaucoma in 4 study groups. The control groups were healthy subjects and patients with primary open angle glaucoma (POAG). The cECD was measured with the endothelial cell mirror microscope (SeaEagle). RESULTS: All study groups and the POAG group showed a significant cECD reduction compared to the healthy control group: POAG: 6.0 %; PEX syndrome: mild 5.5 % and severe 11.0 %, PEX glaucoma: mild 7.7 % and severe 12.3 %. Further the cECD was significantly lower compared to the POAG group in severe PEX syndrome by 5.4 % and in severe PEX glaucoma by 6.8 %. cECD significantly decreased with increasing PEX stage independently of the presence of glaucoma. These differences remained statistically significant after Bonferroni-Holm correction. The analysis of the entire group of test subjects showed only a weak correlation between mean intraocular pressure and mean cECD. CONCLUSION: The results of this study showed a decreasing cECD with increasing PEX stage, regardless of whether glaucoma is present or not. The influence of the PEX process appears to be more pronounced than the influence of intraocular pressure. Georg Thieme Verlag KG Stuttgart · New York.
INTRODUCTION: Pseudoexfoliation (PEX) syndrome is a common, age-related disease which is associated with the multifocal deposition of fibrillar PEX material in intra- and extraocular tissues. Subsequently among others second chronic open-angle glaucoma and corneal endothelial cell loss occurs. The present study analysed whether there is a correlation between the stage of the PEX process and corneal endothelial cell density (cECD), regardless of the non-existence or proof of secondary glaucoma. MATERIALS AND METHODS: One eye of 109 Caucasian subjects (mean age 71.7 years) was examined by slit-lamp microscopy and classified based on visible PEX deposits on the lens (mild and severe) and presence of glaucoma in 4 study groups. The control groups were healthy subjects and patients with primary open angle glaucoma (POAG). The cECD was measured with the endothelial cell mirror microscope (SeaEagle). RESULTS: All study groups and the POAG group showed a significant cECD reduction compared to the healthy control group: POAG: 6.0 %; PEX syndrome: mild 5.5 % and severe 11.0 %, PEX glaucoma: mild 7.7 % and severe 12.3 %. Further the cECD was significantly lower compared to the POAG group in severe PEX syndrome by 5.4 % and in severe PEX glaucoma by 6.8 %. cECD significantly decreased with increasing PEX stage independently of the presence of glaucoma. These differences remained statistically significant after Bonferroni-Holm correction. The analysis of the entire group of test subjects showed only a weak correlation between mean intraocular pressure and mean cECD. CONCLUSION: The results of this study showed a decreasing cECD with increasing PEX stage, regardless of whether glaucoma is present or not. The influence of the PEX process appears to be more pronounced than the influence of intraocular pressure. Georg Thieme Verlag KG Stuttgart · New York.
Authors: Sapna Sinha; Allen Y Ganjei; Melih Ustaoglu; Zeba A Syed; Daniel Lee; Jonathan S Myers; Scott J Fudemberg; Reza Razeghinejad Journal: Graefes Arch Clin Exp Ophthalmol Date: 2021-01-30 Impact factor: 3.117
Authors: Alicia De Maria; Keith D Zientek; Larry L David; Phillip A Wilmarth; Anjali M Bhorade; George J Harocopos; Andrew J W Huang; Augustine R Hong; Carla J Siegfried; Linda M Tsai; Arsham Sheybani; Steven Bassnett Journal: Invest Ophthalmol Vis Sci Date: 2021-12-01 Impact factor: 4.799